NCT05769257View on ClinicalTrials.gov

A Safety and Feasibility Study of IS-001 Injection in Patients Undergoing Robotic Colorectal Surgery

PHASE2CompletedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

June 14, 2023

Primary Completion Date

March 18, 2024

Study Completion Date

April 4, 2024

Conditions

Ureter Injury

Interventions

DRUG

IS-001

Intravenous injection of IS-001 investigational drug

Trial Locations (2)

78758

St. David's North Austin Medical Center, Austin

98405

MultiCare Tacoma General Hospital, Tacoma

Sponsors

Lead Sponsor

Intuitive Surgical

All Listed Sponsors

lead

Intuitive Surgical

INDUSTRY

NCT05769257 - A Safety and Feasibility Study of IS-001 Injection in Patients Undergoing Robotic Colorectal Surgery | Biotech Hunter | Biotech Hunter